Nomura Asset Management CO LTD C4 Therapeutics, Inc. Transaction History

Nomura Asset Management CO LTD

  • $31.8 Billion
  • Q3 2024

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$8.03 - $12.77 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022
BUY
$8.03 - $12.77 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022
BUY
$8.03 - $12.77 $0 - $0
0 New
0 $0
Q2 2022

Aug 12, 2022
BUY
$5.06 - $26.46 $0 - $0
0 New
0 $0
Q1 2022

May 13, 2022
BUY
$19.99 - $33.23 $0 - $0
0 New
0 $0
Q4 2021

Feb 01, 2022
BUY
$29.39 - $46.86 $0 - $0
0 New
0 $0
Q3 2021

Nov 12, 2021
BUY
$35.91 - $50.5 $0 - $0
0 New
0 $0
Q2 2021

Aug 06, 2021
BUY
$30.39 - $42.18 $0 - $0
0 New
0 $0
Q1 2021

May 14, 2021
BUY
$31.96 - $46.5 $0 - $0
0 New
0 $0

Others Institutions Holding CCCC

# of Institutions
130
Shares Held
63.5M
Call Options Held
670K
Put Options Held
54.8K
View Full List

About C4 Therapeutics, Inc.

CCCC Quotes by TradingView
  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $208M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email